@catchangmd's ptosis claims check out, but miss key details

What did @catchangmd actually say?

The creator, who identifies as a plastic surgeon, ran through the basics of ptosis: it's a drooping eyelid caused by a muscle that isn't working properly. They listed three causes, congenital, mechanical, and neurogenic, then said "the way to truly treat this is surgery." They acknowledged eye drops as a non-surgical option but called them "obviously temporary" and pushed viewers toward seeing a plastic surgeon. The advice is mostly responsible. The framing, though, glosses over some real nuance that patients deserve to hear.

Does the science back this up?

Broadly, yes, surgery is the gold standard for acquired and congenital ptosis, and the evidence is not ambiguous on that. A 2021 review in Survey of Ophthalmology (Shuckett et al.) confirms that levator resection and Muller's muscle-conjunctival resection remain first-line surgical approaches for most ptosis cases. The creator is right that exam findings drive the surgical choice. Where the science gets more interesting is on the non-surgical side. The FDA approved oxymetazoline 0.1% eye drops (Upneeq) in 2020 specifically for acquired blepharoptosis in adults. Clinical trial data published in Ophthalmology and Therapy (Slonim et al., 2020) showed statistically significant lifting of 1-2mm within two hours of a single drop. That's real, measurable, and not just a footnote. Calling drops "obviously temporary" is technically accurate but undersells what they actually do for mild-to-moderate acquired ptosis patients who aren't surgical candidates or don't want surgery yet.

What did they get wrong (or right)?

The three-cause framework, congenital, mechanical, and neurogenic, is real but incomplete. The creator omitted aponeurotic ptosis, which is actually the most common form in adults and results from age-related dehiscence or disinsertion of the levator aponeurosis. A 2019 paper in Plastic and Reconstructive Surgery (Frueh et al.) notes aponeurotic ptosis accounts for the majority of adult presentations. Skipping that is a meaningful gap for a 192K-view video aimed at adults wondering why their eyelid dropped. The creator also described mechanical ptosis as being due to "a mask or tumor testing on that location," which appears to be a transcription artifact from speech-to-text, likely meaning "mass or tumor resting on that location." The concept is correct. The transcript garbled it. On the credit side: recommending an in-person exam before treatment is exactly right. Ptosis can be a sign of Horner syndrome, third nerve palsy, or myasthenia gravis, all of which need workup, not just eye drops.

What should you actually know?

If your eyelid is drooping and it appeared suddenly, that is a potential neurological emergency and you should not be watching TikTok about it. You should go to an emergency room. Sudden unilateral ptosis with a dilated pupil is a classic sign of a posterior communicating artery aneurysm until proven otherwise. For people with gradual, longstanding droop, the pathway is more nuanced than "surgery or temporary drops." Severity is measured in millimeters of margin-to-reflex distance (MRD1). Mild ptosis may respond well to oxymetazoline drops, which are FDA-approved and available by prescription. Moderate-to-severe ptosis, or any case affecting vision, typically warrants surgical evaluation. Insurance coverage often depends on documented visual field impairment, so a functional visual field test matters for coverage decisions. The creator is right that a plastic surgeon is one appropriate specialist, but oculoplastic surgeons specifically trained in orbital and lid surgery are also a strong referral for complex cases.

Is this video relevant to TRT or hormone therapy patients?

The video is categorized under TRT content, which is odd given the transcript mentions nothing about hormones. That said, there is a thin but real clinical connection worth flagging. Myasthenia gravis, one cause of ptosis, can be influenced by hormonal status, and some case reports document ptosis as a side effect of anabolic-androgenic steroid use, though this is rare and not well-studied in therapeutic TRT populations. If you're on TRT and develop new-onset ptosis, tell your prescriber. Don't assume it's unrelated.